1 | GB-0998 For Unexplained Recurrent Miscarriage | 2023-005-S | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
2 | Airway Shield | 2023-004-S | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
3 | Capivasertib For Breast Cancer | 2023-002-B | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
4 | Baxdrostat In Patients With Resistant Hypertension | 2023-001-S | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
5 | Aprocitentan In Patients With Resistant Hypertension | 2023-001-B | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
6 | Tirzepatide For Treatment Of Obesity | 2022-010-S | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
7 | Oral Medication For Treatment Of Obstructive Sleep Apnoea | 2022-010-B | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
8 | The Mirvie RNA Platform For Early Detection Of Pre-Eclampsia | 2022-009-S | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
9 | GammaSense for Alzheimer's disease | 2022-009-B | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
10 | Extravascular Implantable Cardioverter-Defibrillator | 2022-008-B | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
11 | Obefazimod (ABX464) For The Treatment Of Ulcerative Colitis | 2022-007-B | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
12 | Nirsevimab For Prevention Of Respiratory Syncytial Virus In Infants | 2022-006-B | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
13 | Etrolizumab For Inflammatory Bowel Disease | 2022-005-S | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
14 | Rewalk Reboot Soft Exoskeleton Device In Stroke Paraplegia Patients | 2022-005-B | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
15 | Tebipenem Pivoxil Hydrobromide In Complicated Urinary Tract Infection | 2022-004-S | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
16 | Automated Virtual Reality Cognitive Therapy (Gamechange) For Agoraphobia Among Psychiatric Patients | 2022-004-B | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
17 | Automated Virtual Reality Cognitive Therapy (gameChange) for Agoraphobia among Psychiatric Patients | 2022-004-B | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
18 | Peripheral Blood Stem Cell (PBSC) For Articular Cartilage Regeneration (An Update) | 2022-003-S | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
19 | Lecanemab (BAN2401) For Alzheimer's Disease | 2022-003-B | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
20 | Zatolmilast (BPN14770) For The Treatment Of Fragile X Syndrome | 2022-002-S | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
21 | Ensifentrine (RPL 554) For The Treatment Of Chronic Obstructive Pulmonary Disease (COPD) | 2022-002-B | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
22 | Iptacopan For The Treatment Of C3 Glomerulopathy | 2022-001-S | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
23 | Daprodustat For Anaemia In Chronic Kidney Disease (CKD) | 2022-001-B | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
24 | Pembrolizumab For Adjuvant Treatment Of Post-Nephrectomy In Renal Cell Carcinoma Patients | 2021-011-S | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |
25 | Efpeglenatide For Renal And Cardiovascular Protection In Type II Diabetes | 2021-010-S | ![View View](https://moh.gov.my/assets/shared/images/admin/magnifier.png) |